Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | TMX | Common Stock | Disposed to Issuer | -15.1K | -100% | 0 | Oct 12, 2022 | Direct | F1, F2 | ||
transaction | TMX | Common Stock | Disposed to Issuer | -1.25K | -100% | 0 | Oct 12, 2022 | by Rebecca A. Hochhauser 2020 Trust | F1, F2 | ||
transaction | TMX | Common Stock | Disposed to Issuer | -1.25K | -100% | 0 | Oct 12, 2022 | By spouse | F1, F2 |
Steven B. Hochhauser is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.
Id | Content |
---|---|
F1 | Represents shares of Terminix Global Holdings, Inc. ("Terminix") common stock disposed of in connection with the Agreement and Plan of Merger, dated as of December 13, 2021, as amended by Amendment No. 1 to the Agreement and Plan of Merger, dated as of March 14, 2022 (the "Merger Agreement"), by and among Terminix, Rentokil Initial plc ("Rentokil Initial") and certain of Rentokil Initial's subsidiaries. In accordance with the Merger Agreement, at the First Effective Time (as defined in the Merger Agreement), each share of Terminix common stock (other than certain excluded shares as described in the Merger Agreement) was converted into the right to receive at the prior election of the holder, either: (x) 1.4899 American depositary shares of Rentokil Initial ("Rentokil Initial ADSs"); or (y) $34.57 in cash and 0.1447 Rentokil Initial ADSs. |
F2 | Each outstanding Terminix director deferred share equivalent ("Terminix DSE") was converted into an amount in cash of $38.29, and otherwise was paid on the same terms and conditions as applicable under the Terminix DSE award agreement. |
In connection with the transaction, the reporting person ceased to be a Section 16 reporting person.